Company intelligence / Profile preview
Shenzhen Weiguang Biological Products
- Ownership
- Private
- Employees
- ~846
- Development stage
- Other
Overview
Shenzhen Weiguang Biological Products has a strong commercial portfolio of blood-derived therapeutics including human albumin and various immunoglobulins. The company also has ongoing late-stage clinical development for new indications such as the use of fibrin adhesive in surgical hemostasis. Its products are widely used across China with a long safety record[1][2][3][9].
- Therapeutic areas
- HematologyImmunologyInfectious Diseases
- Modalities
- AntibodyBiologicProtein
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Shenzhen Weiguang Biological Products.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Weiguang Biological Products.